HeartSciences Announces Pilot Study Results published in launch edition of European Heart Journal-Digital Health

Study demonstrates MyoVista® wavECG™ ability to predict abnormal Calcium Score

Heart disease is a global pandemic affecting at least 26 million people worldwide and continues to increase in prevalence due to increasing life expectancy in the general population. More effective front-line tools are needed that can assist in identifying patients earlier while also lowering costs for health systems around the world. The article is titled “Prediction of coronary artery calcium scoring from surface electrocardiogram in atherosclerotic cardiovascular disease: a pilot study”.  The study evaluated the feasibility of MyoVista Technology to assist in predicting abnormal calcium scores.

Conclusion of the study: “ML techniques can extract information from electrocardiographic data and clinical variables to predict CAC score categories and similarly risk-stratify patients with suspected coronary artery disease.”